0 penilaian0% menganggap dokumen ini bermanfaat (0 suara)
8 tayangan2 halaman
Community-acquired pneumonia affects 5-10 million adults annually in the u.s. Current guidelines recommend fluoroquinolones as monotherapy for treatment of CAP in general medical wards. Doxycycline monotherapy for outpatient therapy only.
Community-acquired pneumonia affects 5-10 million adults annually in the u.s. Current guidelines recommend fluoroquinolones as monotherapy for treatment of CAP in general medical wards. Doxycycline monotherapy for outpatient therapy only.
Community-acquired pneumonia affects 5-10 million adults annually in the u.s. Current guidelines recommend fluoroquinolones as monotherapy for treatment of CAP in general medical wards. Doxycycline monotherapy for outpatient therapy only.
Background: Community-acquired pneumonia (CAP) affects 510 million adults annually in
the United States with approximately 1A1 million hospitalizations. Current guidelines recommend fluoroquinolones as monotherapy for treatment of CAP in general medical wards and doxycycline monotherapy for outpatient therapy only. Fluoroquinolones are expensive and development of bacterial resistance to them has become a concern. Therefore, we studied whether doxycycline is as efficacious as levofloxacin in treatment of CAP in general medical wards. Methods: In this prospective double-blinded trial, non-pregnant adults with clinical and radiological evidence of pneumonia requiring hospitalization were enrolled. Patients who were septic, hypoxic requiring intubations, nursing home residents, diagnosed with severe hepatic or renal dysfunction, recently hospitalized or immunocompromised were excluded from the study. Subjects were randomly assigned to either i.v. levofloxacin 500 mg daily or doxycycline 100 mg twice daily. After discharge, patients were followed for 2 months. Results: There were 30 patients in the levofloxacin group and 35 patients in the doxycycline group. Groups were comparable in both clinical and laboratory profiles. Additionally, efficacy of treatment was not significantly different between the two groups (P = 0A844). Length of stay was 5A7 2A05 days in the levofloxacin group and 4A0 1A82 days in the doxycycline group (P < 0A0012). Failure rate was similar in both groups (P = 0A893). Total antibiotic cost was $122A07 15A84 for levofloxacin and $64A98 24A4 for doxycycline (P < 0A0001). Conclusions: Our study supports doxycycline as an effective and economical alternative therapy for levofloxacin in the empirical treatment of CAP in general medical wards. Keywords: Community-acquired pneumonia, doxycycline, fluoroquinolone, pneumonia Terjemahan
Latar Belakang: Community-acquired pneumonia (CAP) mempengaruhi 5-10 juta orang
dewasa setiap tahun di Amerika Serikat dengan sekitar 1,1 juta orang dirawat di rumah sakit. Pedoman saat ini menyarankan fluoroquinolones sebagai monoterapi untuk pengobatan CAP di bangsal medis umum dan doxycycline monoterapi untuk terapi rawat jalan saja. Fluoroquinolones dirasakan mahal dan pengembangan resistensi bakteri terhadap golongan tersebut telah menjadi perhatian. Oleh karena itu, kami sebagai peneliti mempelajari apakah doxycycline berefek setara dengan levofloxacin dalam pengobatan CAP di lingkungan medis umum.
Metode: penelitian ini bersifat prospective double-blinded, pasien orang dewasa
yang tidak hamil dengan gejala klinis dan bukti radiologi yang menunjukkan pneumonia membutuhkan rawat inap menjadi subyek dalam penelitian ini. Pasien dengan septis, hipoksia membutuhkan intubasi, penghuni panti jompo, didiagnosis dengan gangguan hepar yang berat atau disfungsi ginjal, baru-baru ini dirawat di rumah sakit atau immunocompromised di eksklusi dari penelitian. Subyek secara acak ditunjuk untuk diberikan levofloxacin intravena 500 mg sehari atau doksisiklin 100 mg dua kali sehari. Setelah keluar dari rumah sakit, pasien di follow up selama 2 bulan. Hasil: terdapat 30 pasien dalam kelompok levofloxacin dan 35 pasien dalam kelompok doksisiklin. Kedua kelompok setara dalam profil klinis dan laboratorium. Selain itu, efektivitas pengobatan tidak berbeda secara signifikan antara kedua kelompok (P = 0,844). Lama tinggal di rumah sakit adalah 5,7 2,05 hari pada kelompok levofloxacin dan 4,0 1,82 hari pada kelompok doxycycline (P <0,0012). Tingkat kegagalan adalah tidak jauh berbeda pada kedua kelompok (P = 0,893). Biaya antibiotik total adalah $ 122,07 15,84 untuk levofloxacin dan $ 64,98 24,4 untuk doxycycline (P <0,0001). Kesimpulan: Studi kami (peneliti) mendukung doxycycline sebagai terapi alternatif yang efektif dan ekonomis untuk levofloxacin dalam pengobatan empiris CAP di bangsal medis umum.